Discover

Making sense of chaos in the GLP-1 space

What is a shortage?

We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?

FDA: Tirzepatide Shortage is over, again!

The FDA has ended the shortage for tirzepatide, essential copy compounding ends on Feb 18 and March 19

FDA Warns Against Unapproved GLP-1 Drugs for Weight Loss

The FDA issued a warning about counterfeit Ozempic, research peptides and retatrutide . Medications should be prescribed and filled with state licensed pharmacies

image showing Outsourcing Facilities Association, et al., Plaintiffs, v. U.S. Food and Drug Administration, et al., Defendants. Case No. 4:24-cv-00953-P JOINT STATUS REPORT

Nov 21 Update on Compounded Tirzepatide Availability and Ongoing FDA Reevaluation

OFA vs FDA Case Join report Nov 21

State of Compounding: Summer '24

We put together some data on prices for compounding. Most of the data is from self reported prices from over 6,000 people we’ve polled.